Login to Your Account

Servier, SIMM to Collaborate on Targeted Drug for Breast Cancer

By Shannon Ellis
Staff Writer

Wednesday, October 9, 2013
SHANGHAI – A well-established French biotech company is working with one of China’s most authoritative state drug discovery organizations to develop a drug that could help the country tackle the growing incidence of breast cancer.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription